Speaking to PharmaDispatch yesterday, and following recently announced changes to its Board and Canberra-based secretariat, CEO Liz de Somer said the association's goal is to build a 'renewed momentum'. …
MA's Liz de Somer: 'Critical' to build a 'renewed momentum'
August 2, 2018 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
Disappointment for Australian innovation
July 19, 2019 - - Latest News -
Boehringer Ingelheim acquires new oncology platform
July 19, 2019 - - Latest News -
Gene and cell therapy boost Novartis second quarter
July 19, 2019 - - Latest News -
PhRMA: The risk of international reference pricing
July 18, 2019 - - Latest News -
J&J Innovation recognises undergraduates
July 18, 2019 - - Latest News -
Stakeholder meeting a little different to last time
July 18, 2019 - - Latest News -
Takeda: From CAR-T to off-the-shelf iCAR-T
July 18, 2019 - - Latest News